Dr Sanjay Wijayatilake · Consultant, Neuroanaesthesia & Intensive Care · Clinical Lead, Neuro Intensive Care and Pre Assessment · FRCA · FFICM
Clinical governance for the AI era.
Health-tech teams bring me in to get clinical AI through the scrutiny that stalls NHS adoption. Boards bring me in to be sure it deserves to get through. Behind both: thirty years in medicine, eighteen of them as a consultant in neuroanaesthesia and intensive care, and national governance roles.
What I bring
Clinical judgement, governance credibility and commercial literacy
AI & health technology
Appointed to a Royal College of Anaesthetists committee for expertise in the ethical use of AI. Co-lead of a Faculty-endorsed Delphi study on AI demand-signalling in intensive care, and part of a trust-wide electronic patient record implementation.
AI & health tech →Board & governance
Board member of the Preoperative Association and committee member with the Royal College of Anaesthetists, the Faculty of Intensive Care Medicine and the BMA. Balance-sheet literacy from directing my own company, and an Executive MBA with all taught modules complete.
Board & advisory →Clinical & executive leadership
Eighteen years as a consultant intensivist and currently Clinical Lead for both Neuro Intensive Care and Pre Assessment. Led workforce redesign that saved the Trust around £2 million, built a 30-consultant critical care team, and was recognised nationally for leadership that pairs empathy with strategic impact.
Clinical leadership →Medico-legal expert witness
Independent expert opinion in anaesthesia, neuroanaesthesia and intensive care medicine from a consultant in current NHS and independent practice, with reports prepared to CPR Part 35.
Expert witness →A board-level test for clinical AI
The Five Questions
The Five Questions is the test I put to every clinical AI tool before it touches a patient pathway: safety, fairness, accountability, transparency, sustainability. Built through Royal College committee work and Faculty-endorsed research, it is the difference between AI a board tolerates and AI a board can defend.
Proof, not promises
See a governance review, worked
A one-page, anonymised example of The Five Questions applied to a clinical AI tool: the findings a board saw, the conditions set before approval, and what changed as a result. It shows exactly what an engagement produces.
Exploring a board, executive or advisory role?
I'm open to executive clinical leadership, non-executive director, clinical advisory and health-tech roles where frontline clinical insight, AI governance and a patient-first mindset add value.